Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane

Jeremy Ricci, Dongguk Min, Miyeon Oh, Hyenchong Lim, Won Yoon Chung, Kwang Kyun Park, Mankil Jung

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Daumone, a dauer-inducing pheromone and a series of lipid derivatives were synthesized from daumone to investigate structure-activity trends. Lipid derivatives demonstrated potent in vivo antiangiogenic activity on the chorioallantoic membrane, which exceeded that of fumagillin and thalidomide as reference agents. Among the 11 synthetic compounds tested, new derivatives 3, 11 and 13 showed the most potent antiangiogenic activity, which was twice that of fumagillin and thalidomide, replacing these as the most potent known antiangiogenic agents.

Original languageEnglish
Pages (from-to)747-752
Number of pages6
JournalMedicinal Chemistry
Volume11
Issue number8
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Chorioallantoic Membrane
Thalidomide
Lipids
Angiogenesis Inhibitors
Pheromones
fumagillin

All Science Journal Classification (ASJC) codes

  • Drug Discovery

Cite this

Ricci, Jeremy ; Min, Dongguk ; Oh, Miyeon ; Lim, Hyenchong ; Chung, Won Yoon ; Park, Kwang Kyun ; Jung, Mankil. / Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane. In: Medicinal Chemistry. 2015 ; Vol. 11, No. 8. pp. 747-752.
@article{49018a43afd94fa1909f601f8760d165,
title = "Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane",
abstract = "Daumone, a dauer-inducing pheromone and a series of lipid derivatives were synthesized from daumone to investigate structure-activity trends. Lipid derivatives demonstrated potent in vivo antiangiogenic activity on the chorioallantoic membrane, which exceeded that of fumagillin and thalidomide as reference agents. Among the 11 synthetic compounds tested, new derivatives 3, 11 and 13 showed the most potent antiangiogenic activity, which was twice that of fumagillin and thalidomide, replacing these as the most potent known antiangiogenic agents.",
author = "Jeremy Ricci and Dongguk Min and Miyeon Oh and Hyenchong Lim and Chung, {Won Yoon} and Park, {Kwang Kyun} and Mankil Jung",
year = "2015",
month = "12",
day = "1",
doi = "10.2174/1573406411666150514100630",
language = "English",
volume = "11",
pages = "747--752",
journal = "Medicinal Chemistry",
issn = "1573-4064",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane. / Ricci, Jeremy; Min, Dongguk; Oh, Miyeon; Lim, Hyenchong; Chung, Won Yoon; Park, Kwang Kyun; Jung, Mankil.

In: Medicinal Chemistry, Vol. 11, No. 8, 01.12.2015, p. 747-752.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synthesis of daumone derivatives and their antiangiogenic activities on chorioallantoic membrane

AU - Ricci, Jeremy

AU - Min, Dongguk

AU - Oh, Miyeon

AU - Lim, Hyenchong

AU - Chung, Won Yoon

AU - Park, Kwang Kyun

AU - Jung, Mankil

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Daumone, a dauer-inducing pheromone and a series of lipid derivatives were synthesized from daumone to investigate structure-activity trends. Lipid derivatives demonstrated potent in vivo antiangiogenic activity on the chorioallantoic membrane, which exceeded that of fumagillin and thalidomide as reference agents. Among the 11 synthetic compounds tested, new derivatives 3, 11 and 13 showed the most potent antiangiogenic activity, which was twice that of fumagillin and thalidomide, replacing these as the most potent known antiangiogenic agents.

AB - Daumone, a dauer-inducing pheromone and a series of lipid derivatives were synthesized from daumone to investigate structure-activity trends. Lipid derivatives demonstrated potent in vivo antiangiogenic activity on the chorioallantoic membrane, which exceeded that of fumagillin and thalidomide as reference agents. Among the 11 synthetic compounds tested, new derivatives 3, 11 and 13 showed the most potent antiangiogenic activity, which was twice that of fumagillin and thalidomide, replacing these as the most potent known antiangiogenic agents.

UR - http://www.scopus.com/inward/record.url?scp=84947928670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947928670&partnerID=8YFLogxK

U2 - 10.2174/1573406411666150514100630

DO - 10.2174/1573406411666150514100630

M3 - Article

VL - 11

SP - 747

EP - 752

JO - Medicinal Chemistry

JF - Medicinal Chemistry

SN - 1573-4064

IS - 8

ER -